Category: Globus Medical
Globus Medical shares gain on strong 3rd-quarter results and increased earnings guidance.
Globus Medical (NYSE:GMED) shares gained this week after the medical device company reported strong 3rd-quarter results ahead of Wall Street's expectations and raised its earnings outlook for the rest of the year.
Globus Medical says the FDA issued a warning letter over its MicroFuse bone-growth putty.
Globus Medical (NYSE:GMED) said the FDA issued a warning letter last month over its MicroFuse bone-growth putty, sending share prices down today on Wall Street.
Johnson & Johnson's DePuy Synthes subsidiary goes after a trio of ex-sales reps now working for rival Globus Medical in Texas.
A $16 million patent infringement loss to Johnson & Johnson's DePuy-Synthes subsidiary pushes Globus Medical's 2nd-quarter earnings down, but share prices tick up as it beats Wall Street's expectations.
Globus Medical (NYSE:GMED) shares rose more than 2% last week despite a 61% 2nd-quarter profit slide after the medical device company reported earnings above Wall Street's forecast and confirmed its outlook for the rest of the year.
DePuy Synthes sues a pair of former sales representatives after they jump ship for Sky Surgical, a distributor for rival Globus Medical.
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3 spinal implant products, ruling that Globus Medical owes $16 million in damages.